Haemonetics Corp
NYSE:HAE
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
71.16
97.37
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Haemonetics Corp
Wall Street
Price Targets
HAE Price Targets Summary
Haemonetics Corp
According to Wall Street analysts, the average 1-year price target for
HAE
is 113.02 USD
with a low forecast of 85.85 USD and a high forecast of 131.25 USD.
HAE Last Price Targets
Haemonetics Corp
The latest public price target was made on Nov 8, 2024 by
Andrew Cooper
from
Raymond James
,
who expects
HAE
stock to
rise by 52%
over the next 12 months.
You can read more about this price target by viewing
the article on StreetInsider.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Andrew Cooper
Raymond James
|
120
USD
Upside 52% |
1 month ago
Nov 8, 2024
|
Raymond James Upgrades Haemonetics (HAE) to Strong Buy
StreetInsider
|
|
Kristen Stewart
C.L. King
|
116
USD
Upside 47% |
3 months ago
Sep 13, 2024
|
Haemonetics initiated with a Buy at CL King
TheFly
|
Craig Bijou
Bank of America Securities
|
85
USD
Upside 8% |
3 months ago
Sep 11, 2024
|
BofA Securities Starts Haemonetics (HAE) at Neutral
StreetInsider
|
Mike Matson
Needham
|
112
USD
Upside 42% |
6 months ago
Jun 12, 2024
|
Needham Upgrades Haemonetics (HAE) to Buy
StreetInsider
|
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is HAE's stock price target?
Price Target
113.02
USD
According to Wall Street analysts, the average 1-year price target for
HAE
is 113.02 USD
with a low forecast of 85.85 USD and a high forecast of 131.25 USD.
What is Haemonetics Corp's Revenue forecast?
Projected CAGR
7%
For the last 8 years the
compound annual growth rate for
Haemonetics Corp's revenue is
5%.
The projected
CAGR
for the next 3 years is
7%.
What is Haemonetics Corp's Operating Income forecast?
Projected CAGR
26%
For the last 8 years the
compound annual growth rate for
Haemonetics Corp's operating income is
22%.
The projected
CAGR
for the next 3 years is
26%.
What is Haemonetics Corp's Net Income forecast?
Projected CAGR
38%
The
compound annual growth rate
of Haemonetics Corp's net income for the next 3 years is
38%.
You don't have any saved screeners yet
